Lixisenatide/ZP10 Publications

  • 2010

    8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

    Read More >

  • Meet us

    The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

    Read More >

Lixisenatide/ZP10 Publications

Christensen, M., Knop, F.K., Holst, J.J. and Vilsbøll, T.:
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus
IDrugs 2009, 12, 503-513

Werner, U.:
Preclinical pharmacology of the new GLP-1 receptor agonist AVE0010 Pharmacologie du nouvel agoniste du récepteur GLP-1, le AVE0010
Annales d’Endocrinologie 2008, 69, 164–165

Thorkildsen, C., Neve, S., Larsen, B. D., Meier, E., and Pedersen, J. S.:
GLP-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice.
J. Pharmacol. Exp. Ther., 2003. Vol. 307, No. 2, pp 490-496

Petersen, J.S., Thorkildsen, C., Lundgren, K. and Neve, S.: '
ZP10 - A new GLP-1 agonist that prevents diabetes progression and increases insulin mRNA expression in db/db mice.
38th Annual Meeting of the European Association for the Study of Diabetes (EASD) Budapest, Hungary; 1st - 5th September 2002
Diabetologia, 2002, 45 (Suppl. 1), A147, Abstract no. 447.
Poster presentation

Thorkildsen, C., Petersen, J.S.,Neve, S.: 
ZP10 – a new GLP-1 agonist that increases insulin mRNA expression.
Nedergaard Symposium, Odense, Denmark, January 24, 2002 (Abstract)
Poster presentation

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.



Related links